Affimed N.V. Operating Cycle 2011-2026 | AFMD

Annual Operating Cycle Affimed N.V.

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	95.1	105	289	200	136	184	-	-	-

All numbers in EUR currency

Maximum	Minimum	Average
289	95.1	168

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Adagene ADAG	53.8	$ 2.82	-9.03 %	$ 159 M	China
Aptorum Group Limited APM	4.89	$ 0.83	1.13 %	$ 4.53 M	China
Midatech Pharma plc MTP	245	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	32	-	-1.52 %	$ 24.7 M	USA
Acorda Therapeutics ACOR	394	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	40.8	-	-0.23 %	$ 916 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Brickell Biotech BBI	254	-	-5.38 %	$ 6.06 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Aridis Pharmaceuticals ARDS	59	-	17.91 %	$ 11.1 M	USA
Aeterna Zentaris AEZS	115	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Bristol-Myers Squibb Company BMY	153	$ 59.99	0.1 %	$ 122 B	USA
Amneal Pharmaceuticals AMRX	123	$ 14.65	-0.37 %	$ 4.53 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
BeiGene, Ltd. BGNE	49.5	-	0.49 %	$ 251 B	Cayman-islands
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	360	$ 2.2	-3.08 %	$ 13.8 M	USA